期刊文献+

非小细胞肺癌中MGMT基因启动子过甲基化状况及k-ras表达的相关性 被引量:1

Promoter Hypermethylation of MGMT Gene and Expression of K-ras in Human Non-small-cell Lung Cancer
原文传递
导出
摘要 目的探讨非小细胞肺癌(NSCLC)中DNA修复酶O6-甲基鸟嘌呤-DNA甲基转移酶(MGMT)的过甲基化状况、K-ras的表达及其相关性。方法采用甲基化特异性PCR(MSP)及免疫组化的方法 ,检测术后98例NSCLC组织MGMT基因过甲基化状况、K-ras的表达。结果 98例NSCLC组织中MGMT基因启动子甲基化率为31.6%(31/98),K-ras的阳性表达率为46.9%(46/98),对照组10例正常肺组织中MGMT基因启动子甲基化率及K-ras蛋白的阳性表达率均为0(0/98)。在伴有吸烟史、淋巴结转移、P-TNM分期Ⅲ期的NSCLC患者中,MGMT基因过甲基化率及K-ras的阳性表达率均高于不伴有吸烟史、淋巴结转移及Ⅰ~Ⅱ期的患者(P均<0.05),MGMT基因过甲基化率与K-ras的阳性表达率呈正相关(Rs=0.591,P(0.05)。结论在NSCLC中,MGMT基因启动子过甲基化导致K-ras基因的激活,共同参与非小细胞肺癌的发生、发展。 Objective To investigate the relationgship between the promoter hypermethylation of O6-methylguanine DNA methyltransferase (MGMT) gene and expression of K-ras in non-small-cell lung cancer(NSCLC).Methods Methylation specific PCR (MSP) and immunohistochemical methods were used to detected methylation status of MGMT gene and K-ras expression in 98 patients with NSCLC.Results The rate of the promoter hypermethylation of MGMT gene in 98 NSCLC was 31.6%(31/98),the rate of expression of K-ras was 46.9%(46/98).The MGMT gene promoter methylation rate and K-ras protein expression rate in the control group of 10 normal lung tissue both was 0(0/98).The promoter hypermethylation rate of MGMT gene and the expression of K-ras in NSCLC patients with the stage Ⅲ of P-TNM,lymph node metastasis and smoking patients,was higher than that in patients with stage Ⅰ~Ⅱ,no lymph node metastasis and without smoking.(all P0.05).There was positive correlation between the promoter hypermethylation of MGMT and the expression of K-ras in NSCLC(Rs=0.591,P0.05).Conclusion The promoter hypermethylation of MGMT gene may lead to the activation of K-ras gene.They may take part in NSCLC evolvement.
出处 《医药论坛杂志》 2010年第13期1-4,共4页 Journal of Medical Forum
基金 国家自然科学基金项目(3092457)
关键词 非小细胞肺癌 O6-甲基鸟嘌呤-DNA甲基转移酶 K-RAS Non-small-cell lung cancer O6-methylguanine DNA methyltransferase K-ras
  • 相关文献

参考文献14

  • 1Yang M,Coles BF, Caporaso NE, et al. Lack of association between Caucasian lung cancer risk and 06 - methylguanine- DNA methyhransferase- codon 178 genetic polymorphism [ J ]. Lung Cancer,2004,44 ( 3 ) :281-286.
  • 2Lee S, kim WH, Jung HY, et al. Aberrant CPG island methylation of multiple genes in intrahepatie cholangioearcinoma[ J ]. Am J pathol,2002,161 ( 3 ) : 1015-1022.
  • 3Wang L, Liu H, Zhang Z, et al. Association of genetic variants of O6 - methylguanine - DNA methyhransferase with risk of lung cancer in non - Hispanic Whites [ J ]. Cancer Epidemiol Biomarkers prev, 2006, 15 ( 12 ) : 2364-2569.
  • 4Guo W, Wu S, Liu J, et al. Identification of a small molecule with synthetic lethality for K - ras and protein kinase C iota [ J ]. Cancer Res ,2008 ,68 ( 18 ) :7403-7408.
  • 5Huang CC, Chien WP, Wong RH, et al. NAT2 fast acetylator genotype and MGMT promoter methylation may contribute to gender difference in K - RAS mutation occurrence in Taiwan Residents colorectal cancer [ J ]. Environ Mol Mutagen,2009,50(2) : 127-133.
  • 6De Jong WK, Verpooten GF, Kramer H, et al. Promoter methylation primarily occurs in tumor cells of patients with non- small cell lung cancer[ J]. Anticancer Res, 2009,29( 1 ) :363-369.
  • 7Safar AM, Spencer H, Su X, et al. Promoter hypermethylation for molecular nodal staging in non - small cell lung cancer[ J ]. Arch Pathol Lab Med, 2007,131 ( 6 ) : 936- 941.
  • 8Furonaka O, Takeshima Y, Awaya H, et al. Aberrant methylation and loss of expression of O - methylguanine -DNA methyltransferase in pulmonary squamous cell carcinoma and adenocarcinoma [ J ]. Pathol Int, 2005,55 (6) :303-309.
  • 9杨进,陆友金,张妍蓓,何凤莲,刘荣玉.肺癌组织中MGMT蛋白的表达及其与吸烟的关系[J].安徽医科大学学报,2006,41(6):622-625. 被引量:2
  • 10Kim YT, Park S J, Lee SH, et al. Prognostic implication of aberrant promoter hypermethylation of CpG islands in adenocarcinoma of the lung [ J ]. J Thorae Cardiovasc Surg,2005,130(5 ) : 1378.

二级参考文献6

  • 1Kaur T B, Travaline J M, Gaughan J P, et al. Role of polymorphisms in codons 143 and 160 of the O^6-alkylguanine DNA alkyltransferase gene in lung cancer risk [ J ]. Cancer Epidemiol Biomark Prey,2000,9(3 ) :339 -42.
  • 2Mattem J, Eichhom U, Kaina B, et al. O^6-Methylguanine-DNA methyhransferase activity and sensitivity to cyclophosphamide and cisplatin in human lung cancer xenografts[ J ]. Int J Cancer, 1998,77(6) :919 -22.
  • 3Brabender J, Usadel H, Metzger R,et al. Quantitative O^6-methylguanine DNA methyhransferase methylation analysis in curatively resected non-small cell lung cancer: association with clinical outcome[J]. Clin Cancer Res,2003,9( 1 ) :223 -7.
  • 4Nozoe T, Korenaga D, Kabashima A, et al. Smoking-related increase of O ( 6 ) -methylguanine-DNA methyhransferase expression in squamous cell carcinoma of the esophagus [ J ]. Cancer Lett,2002,184( 1 ) :49 -55.
  • 5Grombacher T, Mitra S, Kaina B. Induction of the alkyhransferase (MGMT) gene by DNA damaging agents and the glucocorticoidd examethasone and comparison with the response of base excision repair genes[ J ]. Carcinogenesis, 1996, 17 ( 11 ) :2329 - 36.
  • 6吕嘉春,施侣元,吴中亮,廖永德,周晟,王孝养,黎银燕,宾晓农,曾波航,陈家堃.DNA修复基因O^6-甲基鸟嘌呤-DNA甲基转移酶在人群肺癌发生中的作用[J].中华流行病学杂志,2003,24(1):40-44. 被引量:9

共引文献6

同被引文献23

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部